276 results on '"Masugi Y"'
Search Results
2. Diagnostic performance of the newly developed endoscopic ultrasound visualization technique for low velocity blood flow in pancreatic ductal adenocarcinoma
- Author
-
Hayakawa, T., additional, Horibe, M., additional, Iwasaki, E., additional, Okada, H., additional, Nakajima, Y., additional, Kayashima, A., additional, Kawsaki, S., additional, Masugi, Y., additional, Kitago, M., additional, and Kanai, T., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Spatial Transcriptional Profiling of the Bronchiolectatic Lungs With Non-cystic Fibrosis Bronchiectasis (NCFB)
- Author
-
Asakura, T., primary, Dang, H., additional, Okuda, K., additional, Chen, G., additional, Kato, T., additional, Mikami, Y., additional, Gilmore, R.C., additional, Hawkins, P., additional, Schworer, S.A., additional, Masugi, Y., additional, Hasegawa, N., additional, Randell, S.H., additional, O'Neal, W.K., additional, and Boucher, R.C., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD-L1) expression in colorectal carcinoma
- Author
-
Ugai, T. (Tomotaka), Shimizu, T. (Takashi), Kawamura, H. (Hidetaka), Ugai, S. (Satoko), Takashima, Y. (Yasutoshi), Usui, G. (Genki), Väyrynen, J. P. (Juha P.), Okadome, K. (Kazuo), Haruki, K. (Koichiro), Akimoto, N. (Naohiko), Masugi, Y. (Yohei), da Silva, A. (Annacarolina), Mima, K. (Kosuke), Zhang, X. (Xuehong), Chan, A. T. (Andrew T.), Wang, M. (Molin), Garrett, W. S. (Wendy S.), Freeman, G. J. (Gordon J.), Meyerhardt, J. A. (Jeffrey A.), Nowak, J. A. (Jonathan A.), Song, M. (Mingyang), Giannakis, M. (Marios), Ogino, S. (Shuji), Ugai, T. (Tomotaka), Shimizu, T. (Takashi), Kawamura, H. (Hidetaka), Ugai, S. (Satoko), Takashima, Y. (Yasutoshi), Usui, G. (Genki), Väyrynen, J. P. (Juha P.), Okadome, K. (Kazuo), Haruki, K. (Koichiro), Akimoto, N. (Naohiko), Masugi, Y. (Yohei), da Silva, A. (Annacarolina), Mima, K. (Kosuke), Zhang, X. (Xuehong), Chan, A. T. (Andrew T.), Wang, M. (Molin), Garrett, W. S. (Wendy S.), Freeman, G. J. (Gordon J.), Meyerhardt, J. A. (Jeffrey A.), Nowak, J. A. (Jonathan A.), Song, M. (Mingyang), Giannakis, M. (Marios), and Ogino, S. (Shuji)
- Abstract
Objectives: The CD274 (programmed cell death 1 ligand 1, PD-L1)/PDCD1 (programmed cell death 1, PD-1) immune checkpoint axis is known to regulate the antitumor immune response. Evidence also supports an immunosuppressive effect of Fusobacterium nucleatum. We hypothesised that tumor CD274 overexpression might be inversely associated with abundance of F. nucleatum in colorectal carcinoma. Methods: We assessed tumor CD274 expression by immunohistochemistry and F. nucleatum DNA within tumor tissue by quantitative PCR in 812 cases among 4465 incident rectal and colon cancer cases that had occurred in two prospective cohort studies. Multivariable logistic regression analyses with inverse probability weighting were used to adjust for selection bias because of tissue data availability and potential confounders including microsatellite instability status, CpG island methylator phenotype, LINE-1 methylation level and KRAS, BRAF and PIK3CA mutations. Results: Fusobacterium nucleatum DNA was detected in tumor tissue in 109 (13%) cases. Tumor CD274 expression level was inversely associated with the amount of F. nucleatum in colorectal cancer tissue (P = 0.0077). For one category-unit increase in three ordinal F. nucleatum categories (negative vs. low vs. high), multivariable-adjusted odds ratios (with 95% confidence interval) of the low, intermediate and high CD274 categories (vs. negative) were 0.78 (0.41–1.51), 0.64 (0.32–1.28) and 0.50 (0.25–0.99), respectively (Ptrend = 0.032). Conclusions: Tumor CD274 expression level was inversely associated with the amount of F. nucleatum in colorectal cancer tissue, suggesting that different immunosuppressive mechanisms (i.e. PDCD1 immune checkpoint activation and tumor F. nucleatum enrichment) tend to be used by different tumor subgroups.
- Published
- 2023
5. Upregulation of integrin β4 promotes epithelial–mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma
- Author
-
Masugi, Y, Yamazaki, K, Emoto, K, Effendi, K, Tsujikawa, H, Kitago, M, Itano, O, Kitagawa, Y, and Sakamoto, M
- Published
- 2015
- Full Text
- View/download PDF
6. Additional file 1 of Epstein–Barr virus-associated inflammatory pseudotumor variant of follicular dendritic cell sarcoma of the liver: a case report and review of the literature
- Author
-
Abe, K., Kitago, M., Matsuda, S., Shinoda, M., Yagi, H., Abe, Y., Oshima, G., Hori, S., Endo, Y., Yokose, T., Miura, E., Kubota, N., Ueno, A., Masugi, Y., Ojima, H., Sakamoto, M., and Kitagawa, Y.
- Abstract
Additional file 1. Supplementary Figures and Tables.
- Published
- 2023
- Full Text
- View/download PDF
7. Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma
- Author
-
Baba, Yuko, Funakoshi, T., Mori, M., Emoto, K., Masugi, Y., Ekmekcioglu, S., Amagai, M., and Tanese, K.
- Published
- 2017
- Full Text
- View/download PDF
8. MUC5B-Dominated Mucus Hyperproduction in the Bronchiolectatic Airway of Non-Cystic Fibrosis Bronchiectasis (NCFB)
- Author
-
Asakura, T., primary, Okuda, K., additional, Chen, G., additional, Kato, T., additional, Mikami, Y., additional, Rodney, G.C., additional, Barbosa Cardenas, S.M., additional, Chua, M., additional, Masugi, Y., additional, Noone, P.G., additional, Ribeiro, C.M.P., additional, Doerschuk, C.M., additional, Olivier, K.N., additional, Hasegawa, N., additional, Randell, S.H., additional, O'Neal, W.K., additional, and Boucher, R.C., additional
- Published
- 2022
- Full Text
- View/download PDF
9. 357: Molecular characterization of airway in non-cystic fibrosis bronchiectasis
- Author
-
Asakura, T., primary, Okuda, K., additional, Chen, G., additional, Gilmore, R., additional, Kato, T., additional, Mikami, Y., additional, Cardenas, S. Barbosa, additional, Chua, M., additional, Masugi, Y., additional, Noone, P., additional, Ribeiro, C., additional, Doerschuk, C., additional, Hasegawa, N., additional, Randell, S., additional, O’Neal, W., additional, and Boucher, R., additional
- Published
- 2021
- Full Text
- View/download PDF
10. Association of PIK3CA mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma
- Author
-
Ugai, T. (Tomotaka), Zhao, M. (Melissa), Shimizu, T. (Takashi), Akimoto, N. (Naohiko), Shi, S. (Shanshan), Takashima, Y. (Yasutoshi), Zhong, R. (Rong), Lau, M. C. (Mai Chan), Haruki, K. (Koichiro), Arima, K. (Kota), Fujiyoshi, K. (Kenji), Langworthy, B. (Benjamin), Masugi, Y. (Yohei), da Silva, A. (Annacarolina), Nosho, K. (Katsuhiko), Baba, Y. (Yoshifumi), Song, M. (Mingyang), Chan, A. T. (Andrew T.), Wang, M. (Molin), Meyerhardt, J. A. (Jeffrey A.), Giannakis, M. (Marios), Väyrynen, J. P. (Juha P.), Nowak, J. A. (Jonathan A.), Ogino, S. (Shuji), Ugai, T. (Tomotaka), Zhao, M. (Melissa), Shimizu, T. (Takashi), Akimoto, N. (Naohiko), Shi, S. (Shanshan), Takashima, Y. (Yasutoshi), Zhong, R. (Rong), Lau, M. C. (Mai Chan), Haruki, K. (Koichiro), Arima, K. (Kota), Fujiyoshi, K. (Kenji), Langworthy, B. (Benjamin), Masugi, Y. (Yohei), da Silva, A. (Annacarolina), Nosho, K. (Katsuhiko), Baba, Y. (Yoshifumi), Song, M. (Mingyang), Chan, A. T. (Andrew T.), Wang, M. (Molin), Meyerhardt, J. A. (Jeffrey A.), Giannakis, M. (Marios), Väyrynen, J. P. (Juha P.), Nowak, J. A. (Jonathan A.), and Ogino, S. (Shuji)
- Abstract
Immunotherapy targeting the CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint axis has emerged as a promising treatment strategy for various cancers. Experimental evidence suggests that phosphatidylinositol-4,5-bisphosphonate 3-kinase (PI3K) signaling may upregulate CD274 expression. Thus, we hypothesized that PIK3CA mutation, PTEN loss, or their combined status might be associated with CD274 overexpression in colorectal carcinoma. We assessed tumor CD274 and PTEN expression by immunohistochemistry and assessed PIK3CA mutation by pyrosequencing in 753 patients among 4,465 incident rectal and colon cancer cases that had occurred in two U.S.-wide prospective cohort studies. To adjust for potential confounders and selection bias due to tissue availability, inverse probability weighted multivariable ordinal logistic regression analyses used the 4,465 cases and tumoral data including microsatellite instability, CpG island methylator phenotype, KRAS and BRAF mutations. PIK3CA mutation and loss of PTEN expression were detected in 111 of 753 cases (15%) and 342 of 585 cases (58%), respectively. Tumor CD274 expression was negative in 306 (41%), low in 195 (26%), and high in 252 (33%) of 753 cases. PTEN loss was associated with CD274 overexpression [multivariable odds ratio (OR) 1.83; 95% confidence interval (CI), 1.22–2.75; P = .004]. PIK3CA mutation was statistically-insignificantly (P = .036 with the stringent alpha level of 0.005) associated with CD274 overexpression (multivariable OR, 1.54; 95% CI, 1.03–2.31). PIK3CA-mutated PTEN-lost tumors (n = 33) showed higher prevalence of CD274-positivity (82%) than PIK3CA-wild-type PTEN-lost tumors (n = 204; 70% CD274-positivity) and PTEN-expressed tumors (n = 147; 50% CD274-positivity) (P = .003). Our findings support the role of PI3K signaling in the CD274/PDCD1 pathway.
- Published
- 2021
11. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer
- Author
-
Haruki, K. (Koichiro), Kosumi, K. (Keisuke), Hamada, T. (Tsuyoshi), Twombly, T. S. (Tyler S.), Vayrynen, J. P. (Juha P.), Kim, S. A. (Sun A.), Masugi, Y. (Yohei), Qian, Z. R. (Zhi Rong), Mima, K. (Kosuke), Baba, Y. (Yoshifumi), da Silva, A. (Annacarolina), Borowsky, J. (Jennifer), Arima, K. (Kota), Fujiyoshi, K. (Kenji), Lau, M. C. (Mai Chan), Li, P. (Peilong), Guo, C. (Chunguang), Chen, Y. (Yang), Song, M. (Mingyang), Nowak, J. A. (Jonathan A.), Nishihara, R. (Reiko), Yanaga, K. (Katsuhiko), Zhang, X. (Xuehong), Wu, K. (Kana), Bullman, S. (Susan), Garrett, W. S. (Wendy S.), Huttenhower, C. (Curtis), Meyerhardt, J. A. (Jeffrey A.), Giannakis, M. (Marios), Chan, A. T. (Andrew T.), Fuchs, C. S. (Charles S.), Ogino, S. (Shuji), Haruki, K. (Koichiro), Kosumi, K. (Keisuke), Hamada, T. (Tsuyoshi), Twombly, T. S. (Tyler S.), Vayrynen, J. P. (Juha P.), Kim, S. A. (Sun A.), Masugi, Y. (Yohei), Qian, Z. R. (Zhi Rong), Mima, K. (Kosuke), Baba, Y. (Yoshifumi), da Silva, A. (Annacarolina), Borowsky, J. (Jennifer), Arima, K. (Kota), Fujiyoshi, K. (Kenji), Lau, M. C. (Mai Chan), Li, P. (Peilong), Guo, C. (Chunguang), Chen, Y. (Yang), Song, M. (Mingyang), Nowak, J. A. (Jonathan A.), Nishihara, R. (Reiko), Yanaga, K. (Katsuhiko), Zhang, X. (Xuehong), Wu, K. (Kana), Bullman, S. (Susan), Garrett, W. S. (Wendy S.), Huttenhower, C. (Curtis), Meyerhardt, J. A. (Jeffrey A.), Giannakis, M. (Marios), Chan, A. T. (Andrew T.), Fuchs, C. S. (Charles S.), and Ogino, S. (Shuji)
- Abstract
Fusobacterium nucleatum (F. nucleatum), which has been associated with colorectal carcinogenesis, can impair anti‐tumour immunity, and actively invade colon epithelial cells. Considering the critical role of autophagy in host defence against microorganisms, we hypothesised that autophagic activity of tumour cells might influence the amount of F. nucleatum in colorectal cancer tissue. Using 724 rectal and colon cancer cases within the Nurses‘ Health Study and the Health Professionals Follow‐up Study, we evaluated autophagic activity of tumour cells by immunohistochemical analyses of BECN1 (beclin 1), MAP1LC3 (LC3), and SQSTM1 (p62) expression. We measured the amount of F. nucleatum DNA in tumour tissue by quantitative polymerase chain reaction (PCR). We conducted multivariable ordinal logistic regression analyses to examine the association of tumour BECN1, MAP1LC3, and SQSTM1 expression with the amount of F. nucleatum, adjusting for potential confounders, including microsatellite instability status; CpG island methylator phenotype; long‐interspersed nucleotide element‐1 methylation; and KRAS, BRAF, and PIK3CA mutations. Compared with BECN1‐low cases, BECN1‐intermediate and BECN1‐high cases were associated with lower amounts of F. nucleatum with odds ratios (for a unit increase in three ordinal categories of the amount of F. nucleatum) of 0.54 (95% confidence interval, 0.29–0.99) and 0.31 (95% confidence interval, 0.16–0.60), respectively (Ptrend < 0.001 across ordinal BECN1 categories). Tumour MAP1LC3 and SQSTM1 levels were not significantly associated with the amount of F. nucleatum (Ptrend > 0.06). Tumour BECN1, MAP1LC3, and SQSTM1 levels were not significantly associated with patient survival (Ptrend > 0.10). In conclusion, tumour BECN1 expression is inversely associated with the amount of F. nucleatum in colorectal cancer tissue, suggesting a possible role of autophagy in the elimination of invasive microorganisms.
- Published
- 2020
12. Serum Krebs Von Den Lungen-6 Level in the Prognosis, Disease Progression, and Treatment of Mycobacterium Avium Complex Lung Disease
- Author
-
Asakura, T., primary, Kimizuka, Y., additional, Nishimura, T., additional, Suzuki, S., additional, Masugi, Y., additional, Ishii, M., additional, and Hasegawa, N., additional
- Published
- 2020
- Full Text
- View/download PDF
13. P1.01-51 Micropapillary Predominant and Pathologic Stage Were Risk Factors for Postoperative Brain Metastasis in Lung Adenocarcinoma
- Author
-
Shigenobu, T., primary, Masugi, Y., additional, Hanawa, R., additional, Tajima, A., additional, and Takahashi, Y., additional
- Published
- 2019
- Full Text
- View/download PDF
14. Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature
- Author
-
Takada, S., primary, Hoshino, Y., additional, Ito, H., additional, Masugi, Y., additional, Terauchi, T., additional, Endo, K., additional, Kimata, M., additional, Furukawa, J., additional, Shinozaki, H., additional, Kobayashi, K., additional, and Ogata, Y., additional
- Published
- 2014
- Full Text
- View/download PDF
15. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it
- Author
-
Nogami, Y., primary, Banno, K., additional, Irie, H., additional, Iida, M., additional, Kisu, I., additional, Masugi, Y., additional, Tanaka, K., additional, Tominaga, E., additional, Okuda, S., additional, Murakami, K., additional, and Aoki, D., additional
- Published
- 2014
- Full Text
- View/download PDF
16. Increased Plasma Levels of High Mobility Group Box 1 in Patients with Acute Liver Failure
- Author
-
Oshima, G., primary, Shinoda, M., additional, Tanabe, M., additional, Ebinuma, H., additional, Nishiyama, R., additional, Takano, K., additional, Yamada, S., additional, Miyasho, T., additional, Masugi, Y., additional, Matsuda, S., additional, Suda, K., additional, Fukunaga, K., additional, Matsubara, K., additional, Hibi, T., additional, Yagi, H., additional, Hayashida, T., additional, Yamagishi, Y., additional, Obara, H., additional, Itano, O., additional, Takeuchi, H., additional, Kawachi, S., additional, Saito, H., additional, Maruyama, I., additional, and Kitagawa, Y., additional
- Published
- 2012
- Full Text
- View/download PDF
17. Molecular Diagnosis of Multistage Hepatocarcinogenesis
- Author
-
Sakamoto, M., primary, Effendi, K., additional, and Masugi, Y., additional
- Published
- 2010
- Full Text
- View/download PDF
18. Intranuclear rod-shaped actin filament bundles in poorly differentiated axillary adenosquamous cell carcinoma.
- Author
-
Fukuda, Yuh, Uchiyama, Shoichi, Masuda, Yukinari, Masugi, Yozo, Fukuda, Y, Uchiyama, S, Masuda, Y, and Masugi, Y
- Published
- 1987
- Full Text
- View/download PDF
19. Localization and Persistence of Group A Streptococci Labeled with Fluorescein Isothiocyanate in the Reticuloendothelial System of Mice
- Author
-
Kimura Y, H Konno, Masugi Y, and H Okuni
- Subjects
Streptococcus ,medicine ,General Medicine ,Biology ,medicine.disease_cause ,Virology ,Microbiology ,Persistence (computer science) - Abstract
レンサ球菌に螢光色素(fluorescein isothiocyanate; FITC)を直接標識し,マウス生体内に投与し,FITCを指標に生体内における菌体の局在性ならびに持続性について検討した。FITC終濃度100mcg/ml以上では室温で短時間で標識されるが,低濃度でも,作用時間を長くすればよく標識されるようになつた。またFITC 50mcg/ml以下では菌のviabilityに影響なく,100mcg/mlでは菌のブドウ糖分解能にも影響を与えなかつた。標識された菌体(ないしは菌体成分)は,生菌を投与した場合も死菌を投与した場合も共に45日以上にわたり,主として肝脾などの網内系を中心に局在し,15日以降においてはFITC標識物質は小さな粒子状となつて存在し,それはまた細胞壁のムコペプチド分画であろうことを考察した。またそれらは一部心腎にも検出された。生体内において菌体ないしは菌体成分の局在持続性を検討する上において,菌体ないしは菌体成分にFITCを標識する方法は,組織グラム染色より優れていると思われ,また宿主寄生体関係の研究の上にも有力な手段となるように思える。
- Published
- 1971
20. Localization and Persistence of Group A Streptococcal Cell Walls Related to Cardiac Lesions in Mice
- Author
-
H Konno, H Okuni, H Shimizu, Kimura Y, and Masugi Y
- Subjects
Streptococcus ,business.industry ,General Medicine ,medicine.disease_cause ,Group A ,Persistence (computer science) ,Microbiology ,Cell wall ,chemistry.chemical_compound ,chemistry ,medicine ,Peptidoglycan ,business ,STREPTOCOCCAL INFECTIONS - Abstract
A群レンサ球菌5型菌(T5B株)より細胞壁分画を得,これをマウス腹腔に投与し,経時的にと殺して細胞壁成分の局在持続性につき螢光抗体法を用いて検討し,合わせて心臓における病理組織学的検討を行なつた。その結果C-多糖体,ペプチドグリカンが共に45日以上にわたり肝・脾などの網内系ならびに心臓に局在し,とくにプロナーゼ処理細胞壁投与マウスにおいては10日目で,また未処置細胞壁投与マウスでは1ヵ月後に心筋に強い肉芽腫を形成しえた。そしてこれらの病変は,投与後2日目頃よりファイブロブラスト様の細胞が出現したこと,病変部位に抗体の証明ができなかつたこと,毛細管沈降反応の感度では血清抗体をチェックしえなかつたこと,などから恐らくは細胞壁,とくにC-多糖体・ペプチドグリカン複合体のもつ生物活性に基づく直接的な作用により惹起されたものと推定した。
- Published
- 1972
21. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage
- Author
-
Fukuda, Y., Ishizaki, M., Masuda, Y., GO KIMURA, Kawanami, O., and Masugi, Y.
- Subjects
Pulmonary Alveoli ,Microscopy, Electron ,Pulmonary Fibrosis ,Humans ,respiratory system ,Lung ,Cell Division ,respiratory tract diseases ,Research Article - Abstract
For a study of the processes and mechanisms of pulmonary structural remodeling in fibrotic lungs and metaplastic squamous epithelial cells in fibrotic alveoli, immunohistochemical, ultrastructural, and light-microscopic morphometric observations were made of the lungs in acute and proliferative stages of diffuse alveolar damage (n = 40) obtained from biopsies and autopsies. Morphometry showed that intraalveolar fibrosis developed in the early proliferative stage and was more prominent than interstitial fibrosis. In the early proliferative stage, activated myofibroblasts migrated into intraalveolar spaces through gaps in the epithelial basement membrane. They then attached to the luminal side of epithelial basement membrane and produced intraalveolar fibrosis and coalescence of alveolar walls. This intraalveolar fibrosis was the essential factor in the remodeled lungs. Albumin, fibrinogen, immunoglobulins, and surfactant apoprotein were present throughout the hyaline membrane. Fibronectin was not found in hyaline membrane of the lesions in early acute stage but was demonstrated in later stages in outer layers of hyaline membranes and in the areas of intraalveolar fibrosis. Fibronectin may be responsible for the migration and proliferation of myofibroblasts in intraalveolar spaces. Metaplastic single-layered and stratified squamous epithelial cells were keratin-positive and surfactant apoprotein-negative. These metaplastic epithelial cells were frequently found in the alveoli with minimal Type II epithelial cell proliferation and in the grossly scarred alveoli.
22. Osteoma of the Tongue
- Author
-
PEIMER, R., primary, DREIZIN, D. H., additional, and MASUGI, Y., additional
- Published
- 1956
- Full Text
- View/download PDF
23. Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy
- Author
-
Yoshida Go J, Fuchimoto Yasushi, Osumi Tomoo, Shimada Hiroyuki, Hosaka Seiichi, Morioka Hideo, Mukai Makio, Masugi Yohei, Sakamoto Michiie, and Kuroda Tatsuo
- Subjects
Li-Fraumeni syndrome (LFS) ,cancer stem cells (CSCs) ,CD44 variant isoforms ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Li-Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome that is commonly associated with a germline mutation in the tumor suppressor gene p53. Loss of p53 results in increased expression of CD44, a cancer stem cell (CSC) marker, which is involved in the scavenging of reactive oxygen species (ROS). Here, we report a change in the expression of a CD44 variant isoform (CD44v8-10) in an 8-year-old female LFS patient with osteosarcoma and atypical liver cancer after chemotherapy. Case presentation The patient visited a clinic with a chief complaint of chronic pain in a bruise on her right knee. Magnetic resonance imaging (MRI) raised the possibility of a bone malignancy. Biochemical testing also revealed significantly elevated levels of AFP, which strongly suggested the existence of a primary malignancy in the liver. MRI imaging showed the simultaneous development of osteosarcoma and liver cancer, both of which were confirmed upon biopsy. Combined therapy with surgical resection after chemotherapy was successful in this patient. Regardless of the absence of a familial history of hereditary cancer, a germline mutation in p53 was identified (a missense mutation defined as c.722 C>T, p.Ser241Phe). To better understand the cancer progression and response to treatment, immunohistochemical (IHC) analysis of biopsy specimens obtained before and after chemotherapy was performed using a specific antibody against CD44v8-10. Conclusion This case demonstrates the ectopic up-regulation of CD44v8-10 in a biopsy sample obtained after cytotoxic chemotherapy, which confers high levels of oxidative stress on cancer cells. Because the alternative splicing of CD44 is tightly regulated epigenetically, it is possible that micro-environmental stress resulting from chemotherapy caused the ectopic induction of CD44v8-10 in vivo.
- Published
- 2012
- Full Text
- View/download PDF
24. Modified Intravascular Stent for Microvascular Suture in a Rat Superficial Femoral Artery.
- Author
-
Maeda K, Suzuki T, Masugi Y, Tsuji O, Iwamoto T, and Nakamura M
- Abstract
Background: Intravascular stent (IVaS) is sometimes used for suturing small vessels, but removing the stent after suturing is difficult. To overcome this problem, we developed an IVaS that integrates a stent and a manipulating string. This study aimed to investigate the usefulness of the modified IVaS (M-IVaS) by comparing it with conventional sutures (CS) and conventional IVaS (C-IVaS)., Methods: Forty-five superficial femoral arteries from rats were resected and sutured. The rats were randomly divided into the following 3 groups: CS, M-IVaS, and C-IVaS, with 15 rats per group. Patency rate, operating time, and ultrasonographic blood flow dynamics were examined immediately after suturing. Patency tests, ultrasonographic evaluations, and histological investigations were performed 1 week (n = 5), 2 weeks (n = 5), and 6 weeks (n = 5) after surgery., Results: The 3 groups showed vessel patency in all cases immediately after suturing and at 1 week, 2 weeks, and 6 weeks after surgery. The mean operative time was 22.6 minutes for the CS group, 21.5 minutes for the M-IVaS group, and 25.9 minutes for the C-IVaS group. There were no significant differences in peak flow velocity and stenosis rate among the 3 groups as evaluated by ultrasonography. Histopathological evaluation revealed a similar recovery process of endothelial cells and no damage to the vascular wall., Conclusion: The surgical time using M-IVaS was significantly shorter compared to that using C-IVaS. The M-IVaS reduced the inconvenience of C-IVaS removal. M-IVaS showed the same effectiveness as did the CS in terms of patency rate, operating time, ultrasonographic blood flow dynamics, and histological evaluation. M-IVaS can be used in the field of microsurgery., Competing Interests: Conflicts of interest and sources of funding: The authors are on the following related patents: Patent application of intravascular stent, #2022-121542 filed in the Japan Patent Office. This does not alter our adherence to journal policies on sharing data and materials. The authors have no conflicts of interest to declare., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
25. Molecular diagnosis for detecting KRAS mutation in peritoneal washing fluid of pancreatic ductal adenocarcinoma.
- Author
-
Shimane G, Nakano Y, Matsuda S, Kitago M, Masugi Y, Nakamura K, Nakamura Y, Yagi H, Abe Y, Hasegawa Y, Hori S, Tanaka M, Takemura R, Nishihara H, and Kitagawa Y
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Peritoneal Lavage, Aged, 80 and over, Ascitic Fluid pathology, ROC Curve, Sensitivity and Specificity, Adult, Carcinoma, Pancreatic Ductal genetics, Carcinoma, Pancreatic Ductal diagnosis, Carcinoma, Pancreatic Ductal pathology, Proto-Oncogene Proteins p21(ras) genetics, Mutation, Pancreatic Neoplasms genetics, Pancreatic Neoplasms diagnosis, Pancreatic Neoplasms pathology
- Abstract
Positive peritoneal washing cytology is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma (PDAC); however, its sensitivity is relatively low. This study evaluated the performance of peptide nucleic acid (PNA)-directed PCR clamping as a molecular-based peritoneal washing cytology for sensitive detection of KRAS mutation in PDAC. Intraoperative peritoneal washing fluid (IPWF) obtained from patients with PDAC who underwent surgery was analyzed. PNA-directed PCR clamping was performed on DNA extracted from IPWF. Among 54 patients enrolled, threshold cycle (Ct) was significantly lower in patients with positive peritoneal washing cytology than in those with negative peritoneal washing cytology (P < 0.001) and in patients with peritoneal dissemination than in those without peritoneal dissemination (P < 0.01). The optimal Ct cut-off to predict KRAS mutations in IPWF was 36.42 based on a receiver operating characteristic curve. The sensitivity, specificity, and accuracy for molecular diagnosis were 100%, 80.0%, and 85.2%, respectively. Peritoneal dissemination recurrence was significantly more frequent in patients with a positive molecular diagnosis than in those with a negative diagnosis (38.9 vs. 8.0%, P = 0.013). The genomic approach might be clinically valuable for a more precise tumor cell detection in IPWF., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
26. Distinctive clinical features of radiological pleuroparenchymal fibroelastosis with nontuberculous mycobacterial pulmonary disease: A multicenter retrospective cohort study.
- Author
-
Tanaka H, Asakura T, Okamori S, Furuuchi K, Yagi M, Nakayama Y, Kuramoto J, Yagi K, Hase I, Kamata H, Fujiwara K, Nakao A, Masugi Y, Sato Y, Kanai Y, Namkoong H, Fukunaga K, Nakagawa T, Morimoto K, Fujita M, and Hasegawa N
- Abstract
Objectives: To compare the characteristics and prognosis of patients with nontuberculous mycobacterial (NTM) pulmonary disease (PD) with pleuroparenchymal fibroelastosis (PPFE) with those of patients with nodular/bronchiectatic (NB) and fibrocavitary (FC) NTM-PD., Methods: This multicenter, retrospective, observational study enrolled 32 patients with NTM-PPFE (median age: 70.5 years, 15 females) from six institutions in Japan from January 2003 to December 2018. Their clinical characteristics and response to therapy were compared with age- and sex-matched cohorts of patients with noncavitary NB and cavitary NB/FC NTM-PD., Results: Patients with NTM-PPFE had a lower body mass index and a higher standard NTM-PD therapy initiation rate than patients with other NTM-PD types. Sputum culture conversion rates were comparable between groups; however, patients with NTM-PPFE had a higher incidence of treatment-related adverse events, including optic neuropathy associated with high-dose ethambutol therapy, lower percent predicted forced vital capacity values, higher serum Krebs von den Lungen-6 (KL-6) levels, and poorer treatment outcomes than the other groups. Cox regression revealed that NTM-PPFE was an independent risk factor for death/pneumothorax (adjusted hazard ratio: 35.3, 95% confidence interval: 3.90-4692)., Conclusion: NTM-PPFE is a unique NTM-PD phenotype with a poorer prognosis than the NB and FC phenotypes., Competing Interests: Declarations of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
27. Vitamin D administration increases serum alanine concentrations in thermally injured mice.
- Author
-
Sato Y, Hishiki T, Masugi Y, Florence L, and Yu YM
- Abstract
Thermal or burn injury results in profound metabolic changes in the body. This can contribute to muscle atrophy, bone loss, as well as suppression of the immune system. While the mechanisms that underlie this hypermetabolic response remain unclear, patients with burn injury often have low circulating levels of vitamin D. Vitamin D has been shown to regulate bone formation as well as regulate muscle function. We sought to clarify the effects of vitamin D administration on skeletal muscle function following thermal injury using a mouse model. We found that thermal injury resulted in decreased vitamin D levels as well as decreased bone mineral density. Branched chain amino acid (BCAA)s levels were also significantly enhanced in the serum following burn injury. Vitamin D administration reversed the decrease in bone marrow-derived mesenchymal stem cell (BM-MSC)s observed post burn injury. Interestingly, vitamin D administration also resulted in increased tricarboxylic acid cycle (TCA) cycle metabolites in muscle which was decreased after burn conditions, enhanced the supply of alanine and glutamine in the blood which could contribute to gluconeogenesis and wound healing. Therefore, vitamin D supplementation after burn injury may have effects not only in bone metabolism, but may affect substrate metabolism in other organs/tissues., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition.
- Author
-
Ishida M, Fujii T, Kishiwada M, Shibuya K, Satoi S, Ueno M, Nakata K, Takano S, Uchida K, Ohike N, Masugi Y, Furukawa T, Hirabayashi K, Fukushima N, Yi SQ, Isayama H, Itoi T, Ohtsuka T, Okusaka T, Inoue D, Kitagawa H, Takaori K, Tani M, Nagakawa Y, Yoshitomi H, Unno M, and Takeyama Y
- Abstract
In 2023, the Japan Pancreas Society (JPS) published the new eighth edition of the Japanese classification of pancreatic carcinoma. We present here an excerpted version in English, based on the latest edition. The major changes in this revision are as follows: In the eighth edition of the Union for International Cancer Control (UICC), the T category was changed to be based on tumor size; however, the eighth edition of the Japanese classification retains the previous T category based on local invasion factors. Lymph nodes have been renamed, and regional lymph nodes have been defined by location. Peritoneal cytology, which was not previously included in distant metastasis (M), has now been included in the M category. Moreover, significant additions have been made regarding the pathological diagnosis of endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) and criteria for histological assessment of the effects after chemotherapy and radiation therapy. Although this classification is aimed at carcinoma originating in the pancreas, not in the bile duct or duodenum, if the differentiation of the primary organ is difficult, this classification should be applied. It is also desirable to describe tumors other than carcinoma and metastatic tumors to the pancreas in accordance with this classification., (© 2024 The Author(s). Journal of Hepato‐Biliary‐Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.)
- Published
- 2024
- Full Text
- View/download PDF
29. MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer.
- Author
-
Ozawa H, Haratake N, Nakashoji A, Daimon T, Bhattacharya A, Wang K, Shigeta K, Fushimi A, Fukuda K, Masugi Y, Yamaguchi R, Kitago M, Kawakubo H, Kitagawa Y, and Kufe D
- Abstract
Patients with pancreatic neuroendocrine tumors (pNETs) have limited access to effective targeted agents and invariably succumb to progressive disease. MUC1-C is a druggable oncogenic protein linked to driving pan-cancers. There is no known involvement of MUC1-C in pNET progression. The present work was performed to determine if MUC1-C represents a potential target for advancing pNET treatment. We demonstrate that the MUC1 gene is upregulated in primary pNETs that progress with metastatic disease. In pNET cells, MUC1-C drives E2F- and MYC-signaling pathways necessary for survival. Targeting MUC1-C genetically and pharmacologically also inhibits self-renewal capacity and tumorigenicity. Studies of primary pNET tissues further demonstrate that MUC1-C expression is associated with (i) an advanced NET grade and pathological stage, (ii) metastatic disease, and (iii) decreased disease-free survival. These findings demonstrate that MUC1-C is necessary for pNET progression and is a novel target for treating these rare cancers with anti-MUC1-C agents under clinical development.
- Published
- 2024
- Full Text
- View/download PDF
30. Protective Effects of Hydrogen Gas Inhalation for Hindlimb Ischaemia-Reperfusion Injury in a Mouse Model.
- Author
-
Hayashi M, Obara H, Matsuda S, Homma K, Sasaki J, Matsubara K, Higuchi M, Sano M, Masugi Y, and Kitagawa Y
- Subjects
- Animals, Mice, Administration, Inhalation, Time Factors, Male, Interleukin-6 blood, Interleukin-6 metabolism, Anti-Inflammatory Agents administration & dosage, Anti-Inflammatory Agents pharmacology, Hydrogen administration & dosage, Hydrogen pharmacology, Reperfusion Injury prevention & control, Reperfusion Injury etiology, Reperfusion Injury pathology, Hindlimb, Disease Models, Animal, Muscle, Skeletal blood supply, Muscle, Skeletal drug effects, Muscle, Skeletal pathology
- Abstract
Objective: Ischaemia-reperfusion (I/R) injury is a severe post-operative complication that triggers an inflammatory response and causes severe damage. Hydrogen gas has anti-oxidant and anti-apoptotic properties and has been shown to be safe in humans. The study aimed to investigate whether hydrogen gas protects against skeletal muscle I/R injury., Methods: Experimental basic research using mice. A total of 160 eight to 10 week old albino laboratory bred strain of house mice (25.8 ± 0.68 g) were used in this study. The mice were cable tied to the hindlimb under anaesthesia and then placed in an anaesthesia box filled with air and 2% isoflurane (control group); 80 mice were additionally subjected to 1.3% hydrogen gas in this mix (hydrogen group). After two hours, the cable ties were removed to initiate reperfusion, and hydrogen inhalation lasted for six hours in the hydrogen group. After six hours, the mice were taken out of the box and kept in cages under standard conditions until time for observation at 16 different time points after reperfusion: zero, two, four, six, eight, and 10 hours and one, two, three, four, five, six, seven, 14, 21, and 28 days. Five mice were sacrificed using excess anaesthesia at each time point, and the bilateral hindlimb tissues were harvested. The inflammatory effects of the I/R injury were assessed by evaluating serum interleukin-6 concentrations using enzyme linked immunosorbent assay, as well as histological and immunohistochemical analyses. Untreated mice with I/R injury were used as controls., Results: Hydrogen gas showed protective effects associated with a reduction in inflammatory cell infiltration (neutrophils, macrophages, and lymphocytes), a reduced area of damaged muscle, maintenance of normal muscle cells, and replacement of damaged muscle cells with neoplastic myocytes., Conclusion: Inhalation of hydrogen gas had a protective effect against hindlimb I/R injury in mice, in part by reducing inflammatory cell infiltration and in part by preserving normal muscle cells., (Copyright © 2024 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. Alaska Pollock-derived Gelatin Sealant has Higher Sealing Strength than, and Comparable Biocompatibility with, Fibrin Sealant in Porcine and Rat Dural Injury Models.
- Author
-
Ono T, Suzuki T, Nagoshi N, Masugi Y, Maeda K, Hashimoto S, Watanabe S, Iwamoto T, Taguchi T, and Nakamura M
- Subjects
- Animals, Rats, Swine, Male, Biocompatible Materials, Tissue Adhesives, Materials Testing, Disease Models, Animal, Cerebrospinal Fluid Leak, Fibrin Tissue Adhesive, Dura Mater surgery, Dura Mater drug effects, Gelatin, Rats, Wistar
- Abstract
Study Design: Burst strength study in porcine dural models and functional and histological study in rat dural models., Objective: This study aimed to investigate the sealing strength and biocompatibility of Alaska pollock-derived gelatin (ApGltn) and fibrin sealants in disrupted dural injuries., Summary of Background Data: Disruption of the dura mater occurs during spine surgery, leading to cerebrospinal fluid leakage. Fibrin sealant is usually applied to ruptured sites; however, it lacks sealing strength. A novel biocompatible sealant composed of ApGltn was recently demonstrated to have good burst strength and biocompatibility in the porcine aorta., Methods: Ten porcine dura maters with central holes were covered with ApGltn and fibrin sealants (five samples per group). The maximum burst strength of each sealant was measured, and histological examination was performed after burst testing. Twenty-seven dura maters of male Wistar rats were used for functional and histopathological evaluations. The rats were treated with three surgical interventions: defect + ApGltn sealant; defect + fibrin sealant; defect alone (nine rats per group). Macroscopic confirmation of the sealant, hindlimb motor function analysis, and histopathological examination were performed at two, four, and eight weeks after the procedure., Results: The maximum burst strength of the ApGltn sealant was ~4.4 times higher than that of the fibrin sealant (68.1±12.1 vs . 15.6±8.7 mmHg; P <0.001). Histological examination confirmed that the ApGltn sealant showed tight adhesion to the dural surface, whereas a gap was observed between the fibrin sealant and the dura mater. In the rat model, the ApGltn sealant resulted in spinal function and dural histological findings similar to those of the fibrin sealant., Conclusion: The ApGltn sealant had a higher sealing strength than, and comparable effect on dura regeneration with, the fibrin sealant., Competing Interests: The authors report no conflicts of interest., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. Reciprocal inhibition of the thigh muscles in humans: A study using transcutaneous spinal cord stimulation.
- Author
-
Nakagawa K, Kakehata G, Kaneko N, Masugi Y, Osu R, Iso S, Kanosue K, and Nakazawa K
- Subjects
- Humans, Male, Adult, Muscle, Skeletal physiology, Muscle, Skeletal innervation, Muscle Contraction physiology, Transcutaneous Electric Nerve Stimulation methods, Young Adult, H-Reflex physiology, Femoral Nerve physiology, Neural Inhibition physiology, Quadriceps Muscle physiology, Quadriceps Muscle innervation, Hamstring Muscles physiology, Electromyography, Spinal Cord Stimulation methods, Thigh physiology, Thigh innervation
- Abstract
Evaluating reciprocal inhibition of the thigh muscles is important to investigate the neural circuits of locomotor behaviors. However, measurements of reciprocal inhibition of thigh muscles using spinal reflex, such as H-reflex, have never been systematically established owing to methodological limitations. The present study aimed to clarify the existence of reciprocal inhibition in the thigh muscles using transcutaneous spinal cord stimulation (tSCS). Twenty able-bodied male individuals were enrolled. We evoked spinal reflex from the biceps femoris muscle (BF) by tSCS on the lumber posterior root. We examined whether the tSCS-evoked BF reflex was reciprocally inhibited by the following conditionings: (1) single-pulse electrical stimulation on the femoral nerve innervating the rectus femoris muscle (RF) at various inter-stimulus intervals in the resting condition; (2) voluntary contraction of the RF; and (3) vibration stimulus on the RF. The BF reflex was significantly inhibited when the conditioning electrical stimulation was delivered at 10 and 20 ms prior to tSCS, during voluntary contraction of the RF, and during vibration on the RF. These data suggested a piece of evidence of the existence of reciprocal inhibition from the RF to the BF muscle in humans and highlighted the utility of methods for evaluating reciprocal inhibition of the thigh muscles using tSCS., (© 2024 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.)
- Published
- 2024
- Full Text
- View/download PDF
33. PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer.
- Author
-
Yamamoto T, Hayashida T, Masugi Y, Oshikawa K, Hayakawa N, Itoh M, Nishime C, Suzuki M, Nagayama A, Kawai Y, Hishiki T, Matsuura T, Naito Y, Kubo A, Yamamoto A, Yoshioka Y, Kurahori T, Nagasaka M, Takizawa M, Takano N, Kawakami K, Sakamoto M, Wakui M, Yamamoto T, Kitagawa Y, Kabe Y, Horisawa K, Suzuki A, Matsumoto M, and Suematsu M
- Subjects
- Humans, Drug Resistance, Neoplasm, Serine metabolism, Palmitates, Fatty Acids, Cell Line, Tumor, Protein-Arginine N-Methyltransferases genetics, Repressor Proteins, Phosphoglycerate Dehydrogenase, Triple Negative Breast Neoplasms drug therapy, Triple Negative Breast Neoplasms genetics
- Abstract
Triple-negative breast cancer (TNBC) chemoresistance hampers the ability to effectively treat patients. Identification of mechanisms driving chemoresistance can lead to strategies to improve treatment. Here, we revealed that protein arginine methyltransferase-1 (PRMT1) simultaneously methylates D-3-phosphoglycerate dehydrogenase (PHGDH), a critical enzyme in serine synthesis, and the glycolytic enzymes PFKFB3 and PKM2 in TNBC cells. 13C metabolic flux analyses showed that PRMT1-dependent methylation of these three enzymes diverts glucose toward intermediates in the serine-synthesizing and serine/glycine cleavage pathways, thereby accelerating the production of methyl donors in TNBC cells. Mechanistically, PRMT1-dependent methylation of PHGDH at R54 or R20 activated its enzymatic activity by stabilizing 3-phosphoglycerate binding and suppressing polyubiquitination. PRMT1-mediated PHGDH methylation drove chemoresistance independently of glutathione synthesis. Rather, activation of the serine synthesis pathway supplied α-ketoglutarate and citrate to increase palmitate levels through activation of fatty acid synthase (FASN). Increased palmitate induced protein S-palmitoylation of PHGDH and FASN to further enhance fatty acid synthesis in a PRMT1-dependent manner. Loss of PRMT1 or pharmacologic inhibition of FASN or protein S-palmitoyltransferase reversed chemoresistance in TNBC. Furthermore, IHC coupled with imaging MS in clinical TNBC specimens substantiated that PRMT1-mediated methylation of PHGDH, PFKFB3, and PKM2 correlates with chemoresistance and that metabolites required for methylation and fatty acid synthesis are enriched in TNBC. Together, these results suggest that enhanced de novo fatty acid synthesis mediated by coordinated protein arginine methylation and protein S-palmitoylation is a therapeutic target for overcoming chemoresistance in TNBC., Significance: PRMT1 promotes chemoresistance in TNBC by methylating metabolic enzymes PFKFB3, PKM2, and PHGDH to augment de novo fatty acid synthesis, indicating that targeting this axis is a potential treatment strategy., (©2024 The Authors; Published by the American Association for Cancer Research.)
- Published
- 2024
- Full Text
- View/download PDF
34. Proximal and Distal Bronchioles Contribute to the Pathogenesis of Non-Cystic Fibrosis Bronchiectasis.
- Author
-
Asakura T, Okuda K, Chen G, Dang H, Kato T, Mikami Y, Schworer SA, Gilmore RC, Radicioni G, Hawkins P, Barbosa Cardenas SM, Saito M, Cawley AM, De la Cruz G, Chua M, Alexis NE, Masugi Y, Noone PG, Ribeiro CMP, Kesimer M, Olivier KN, Hasegawa N, Randell SH, O'Neal WK, and Boucher RC
- Subjects
- Humans, Bronchioles, Dilatation, Pathologic, Mucins metabolism, Interleukin-1beta, Fibrosis, RNA, Mucin 5AC genetics, Bronchiectasis genetics, Cystic Fibrosis
- Abstract
Rationale: Non-cystic fibrosis bronchiectasis (NCFB) may originate in bronchiolar regions of the lung. Accordingly, there is a need to characterize the morphology and molecular characteristics of NCFB bronchioles. Objectives: Test the hypothesis that NCFB exhibits a major component of bronchiolar disease manifest by mucus plugging and ectasia. Methods: Morphologic criteria and region-specific epithelial gene expression, measured histologically and by RNA in situ hybridization and immunohistochemistry, identified proximal and distal bronchioles in excised NCFB lungs. RNA in situ hybridization and immunohistochemistry assessed bronchiolar mucus accumulation and mucin gene expression. CRISPR-Cas9-mediated IL-1R1 knockout in human bronchial epithelial cultures tested IL-1α and IL-1β contributions to mucin production. Spatial transcriptional profiling characterized NCFB distal bronchiolar gene expression. Measurements and Main Results: Bronchiolar perimeters and lumen areas per section area were increased in proximal, but not distal, bronchioles in NCFB versus control lungs, suggesting proximal bronchiolectasis. In NCFB, mucus plugging was observed in ectatic proximal bronchioles and associated nonectatic distal bronchioles in sections with disease. MUC5AC and MUC5B mucins were upregulated in NCFB proximal bronchioles, whereas MUC5B was selectively upregulated in distal bronchioles. Bronchiolar mucus plugs were populated by IL-1β-expressing macrophages. NCFB sterile sputum supernatants induced human bronchial epithelial MUC5B and MUC5AC expression that was >80% blocked by IL-1R1 ablation. Spatial transcriptional profiling identified upregulation of genes associated with secretory cells, hypoxia, interleukin pathways, and IL-1β-producing macrophages in mucus plugs and downregulation of epithelial ciliogenesis genes. Conclusions: NCFB exhibits distinctive proximal and distal bronchiolar disease. Both bronchiolar regions exhibit bronchiolar secretory cell features and mucus plugging but differ in mucin gene regulation and ectasia.
- Published
- 2024
- Full Text
- View/download PDF
35. Next‑generation sequencing to identify genetic mutations in pancreatic cancer using intraoperative peritoneal washing fluid.
- Author
-
Nakano Y, Shimane G, Nakamura K, Takamatsu R, Aimono E, Yagi H, Abe Y, Hasegawa Y, Hori S, Tanaka M, Masugi Y, Kitago M, Nishihara H, and Kitagawa Y
- Abstract
The efficacy of next-generation sequencing (NGS) of tumor-derived DNA from intraoperative peritoneal washing fluid (IPWF) of patients with pancreatic ductal adenocarcinoma (PDAC) who intend to undergo curative resection remains unclear. The aim of the present study was to evaluate whether genomic mutations in tumor-derived DNA from IPWF samples of patients with PDAC who intend to undergo curative resection could be detected using NGS. A total of 12 such patients were included in this study. Cytology of IPWF (CY) was assessed and NGS of genomic tumor-derived DNA from the IPWF was performed to determine whether genomic mutations could be detected in these patient samples. A total of 2 patients (16.7%) had a CY(+) status and 1 patient (8.3%) showed intraoperative macro-peritoneal dissemination; 11 patients underwent radical surgery. Actionable gene alterations were detected in 8 (80.0%) out of the 10 patients with CY(-) status based on NGS of IPWF samples, and 3 (37.5%) patients among those with actionable gene mutations identified from IPWF samples underwent peritoneal dissemination after surgery within ~12 months. The most common genomic mutation was in KRAS (9 patients, 75.0%), followed by TP53 (3 patients, 25.0%), SMAD4 (1 patient, 8.3%) and CDKN2A (1 patient, 8.3%). These findings indicated that the genomic mutations identified in tumor-derived DNA from IPWF samples of patients with PDAC with a CY(-) status who intend to undergo curative resection are potential biomarkers for predicting the recurrence of early peritoneal dissemination., Competing Interests: The authors declare that they have no competing interests., (Copyright © 2024, Spandidos Publications.)
- Published
- 2024
- Full Text
- View/download PDF
36. Long-term survival after surgical resection for bone metastasis from pancreatic cancer: A case report.
- Author
-
Hayashi K, Kitago M, Abe Y, Yagi H, Hasegawa Y, Hori S, Tanaka M, Nakano Y, Asakura K, Masugi Y, and Kitagawa Y
- Subjects
- Female, Humans, Middle Aged, Pancreaticoduodenectomy, Positron Emission Tomography Computed Tomography, Pancreatic Neoplasms, Pancreatic Neoplasms surgery, Pancreatic Neoplasms pathology, Bone Neoplasms surgery
- Abstract
Introduction: Pancreatic cancer (PC) is highly malignant and metastatic; however, bone metastases are rare. Although the effectiveness of conversion surgery for distant metastases of PC has been reported in a few cases, there are no reports on surgical resection for bone metastases. Here, we report a case of long-term survival after resection of bone metastasis from PC., Patient Concerns: A 60-year-old woman underwent pancreaticoduodenectomy after neoadjuvant chemoradiotherapy for pancreatic head cancer. At 28 months after surgery, multiple lung metastases from PC were diagnosed, and chemotherapy was administered. After 59 months, chemotherapy was terminated because all target lesions had disappeared on imaging., Diagnosis: At 77 months after the initial surgery, bone metastasis in the left 9th rib was detected by positron emission tomography/computed tomography, which was performed due to elevated carbohydrate antigen 19-9 levels., Interventions: Chemotherapy was readministered as the initial treatment. Subsequently, due to the long-term well-controlled status of the recurrence site and the absence of other metastases, thoracoscopic-assisted partial resection of the left 9th rib was performed 128 months following pancreaticoduodenectomy. Pathological examination revealed adenocarcinoma metastasis from PC., Outcomes: The patient is currently alive without recurrence 44 months after resection for bone metastasis and 172 months after the initial surgery., Conclusion: Surgical resection may be favorable in patients with bone metastasis of PC that is well-controlled with chemotherapy., Competing Interests: The authors have no funding and conflicts of interest to disclose., (Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2023
- Full Text
- View/download PDF
37. Successful radiotherapy for recurrent obstructive pancreatitis secondary to pancreatic metastasis from cervical squamous-cell carcinoma.
- Author
-
Nakajima Y, Iwasaki E, Kayashima A, Machida Y, Kawasaki S, Horibe M, Kawaida M, Masugi Y, Iwata T, and Kanai T
- Subjects
- Female, Humans, Quality of Life, Pancreas pathology, Uterine Cervical Neoplasms radiotherapy, Uterine Cervical Neoplasms pathology, Pancreatic Neoplasms pathology, Pancreatitis, Chronic, Carcinoma, Squamous Cell radiotherapy, Carcinoma, Squamous Cell pathology
- Abstract
Metastatic pancreatic cancer is a rare condition and cases of pancreatic metastasis from cervical cancer are infrequently reported. Furthermore, the incidence rates of pancreatic tumors as the cause of pancreatitis and of pancreatitis in patients with pancreatic tumors are similarly low. Pancreatitis may occur when a tumor obstructs the pancreatic duct. This condition may be difficult to manage and significantly reduces the quality of life because of severe abdominal pain. Here, we present a rare case of obstructive pancreatitis caused by pancreatic metastasis from cervical squamous-cell carcinoma, pathologically confirmed using endoscopic ultrasonography-guided fine-needle biopsy and treated with palliative irradiation to achieve rapid therapeutic relief. It is important to obtain appropriate tissue samples, confirm the pathological diagnosis, and compare the pathological findings with those of the primary tumor to select the appropriate treatment for obstructive pancreatitis caused by a metastatic pancreatic tumor., (© 2023. Japanese Society of Gastroenterology.)
- Published
- 2023
- Full Text
- View/download PDF
38. Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression.
- Author
-
Masugi Y, Takamatsu M, Tanaka M, Hara K, Inoue Y, Hamada T, Suzuki T, Arita J, Hirose Y, Kawaguchi Y, Nakai Y, Oba A, Sasahira N, Shimane G, Takeda T, Tateishi K, Uemura S, Fujishiro M, Hasegawa K, Kitago M, Takahashi Y, Ushiku T, Takeuchi K, and Sakamoto M
- Subjects
- Humans, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Proto-Oncogene Proteins p21(ras) genetics, Mutation, Smad4 Protein genetics, Smad4 Protein metabolism, Cyclin-Dependent Kinase Inhibitor p16 metabolism, Pancreatic Neoplasms, Pancreatic Neoplasms genetics, Pancreatic Neoplasms pathology, Carcinoma
- Abstract
Alterations in KRAS, CDKN2A (p16), TP53, and SMAD4 genes have been major drivers of pancreatic carcinogenesis. The clinical course of patients with pancreatic cancer in relation to these driver alterations has not been fully characterised in large populations. We hypothesised that pancreatic carcinomas with different combinations of KRAS mutation and aberrant expression of CDKN2A, p53, and SMAD4 might show distinctive recurrence patterns and post-operative survival outcomes. To test this hypothesis, we utilised a multi-institutional cohort of 1,146 resected pancreatic carcinomas and assessed KRAS mutations by droplet digital polymerase chain reaction and CDKN2A, p53, and SMAD4 expression by immunohistochemistry. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) for disease-free survival (DFS) and overall survival (OS) were computed according to each molecular alteration and the number of altered genes using the Cox regression models. Multivariable competing risks regression analyses were conducted to assess the associations of the number of altered genes with specific patterns of recurrence. Loss of SMAD4 expression was associated with short DFS (multivariable HR, 1.24; 95% CI, 1.09-1.43) and OS times (multivariable HR, 1.27; 95% CI, 1.10-1.46). Compared to cases with 0-2 altered genes, cases with three and four altered genes had multivariable HRs for OS of 1.28 (95% CI, 1.09-1.51) and 1.47 (95% CI, 1.22-1.78), respectively (p
trend < 0.001). Patients with an increasing number of altered genes were more likely to have short DFS time (ptrend = 0.003) and to develop liver metastasis (ptrend = 0.006) rather than recurrence at local or other distant sites. In conclusion, loss of SMAD4 expression and an increasing number of altered genes were associated with unfavourable outcomes in pancreatic cancer patients. This study suggests that the accumulation of the four major driver alterations can confer a high metastatic potential to the liver, thereby impairing post-operative survival among patients with pancreatic cancer., (© 2023 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland and John Wiley & Sons Ltd.)- Published
- 2023
- Full Text
- View/download PDF
39. Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD-L1) expression in colorectal carcinoma.
- Author
-
Ugai T, Shimizu T, Kawamura H, Ugai S, Takashima Y, Usui G, Väyrynen JP, Okadome K, Haruki K, Akimoto N, Masugi Y, da Silva A, Mima K, Zhang X, Chan AT, Wang M, Garrett WS, Freeman GJ, Meyerhardt JA, Nowak JA, Song M, Giannakis M, and Ogino S
- Abstract
Objectives: The CD274 (programmed cell death 1 ligand 1, PD-L1)/PDCD1 (programmed cell death 1, PD-1) immune checkpoint axis is known to regulate the antitumor immune response. Evidence also supports an immunosuppressive effect of Fusobacterium nucleatum . We hypothesised that tumor CD274 overexpression might be inversely associated with abundance of F. nucleatum in colorectal carcinoma., Methods: We assessed tumor CD274 expression by immunohistochemistry and F. nucleatum DNA within tumor tissue by quantitative PCR in 812 cases among 4465 incident rectal and colon cancer cases that had occurred in two prospective cohort studies. Multivariable logistic regression analyses with inverse probability weighting were used to adjust for selection bias because of tissue data availability and potential confounders including microsatellite instability status, CpG island methylator phenotype, LINE-1 methylation level and KRAS , BRAF and PIK3CA mutations., Results: Fusobacterium nucleatum DNA was detected in tumor tissue in 109 (13%) cases. Tumor CD274 expression level was inversely associated with the amount of F. nucleatum in colorectal cancer tissue ( P = 0.0077). For one category-unit increase in three ordinal F. nucleatum categories (negative vs. low vs. high), multivariable-adjusted odds ratios (with 95% confidence interval) of the low, intermediate and high CD274 categories (vs. negative) were 0.78 (0.41-1.51), 0.64 (0.32-1.28) and 0.50 (0.25-0.99), respectively ( P
trend = 0.032)., Conclusions: Tumor CD274 expression level was inversely associated with the amount of F. nucleatum in colorectal cancer tissue, suggesting that different immunosuppressive mechanisms (i.e. PDCD1 immune checkpoint activation and tumor F. nucleatum enrichment) tend to be used by different tumor subgroups., Competing Interests: ATC previously served as a consultant for Bayer Healthcare and Pfizer Inc. MG was on an advisory board for AstraZeneca and receives research funding from Bristol‐Myers Squibb. JAM has received institutional research funding from Boston Biomedical, has served as an advisor/consultant to Ignyta and COTA Healthcare, and served on a grant review panel for the National Comprehensive Cancer Network funded by Taiho Pharmaceutical. This study was not funded by any of these commercial entities., (© 2023 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.)- Published
- 2023
- Full Text
- View/download PDF
40. Immunovascular microenvironment in relation to prognostic heterogeneity of WNT/β-catenin-activated hepatocellular carcinoma.
- Author
-
Matsuda K, Kurebayashi Y, Masugi Y, Yamazaki K, Ueno A, Tsujikawa H, Ojima H, Kitago M, Itano O, Shinoda M, Abe Y, and Sakamoto M
- Abstract
Aim: WNT/β-catenin-activated hepatocellular carcinoma (W/B subclass HCC) is considered a molecularly homogeneous entity and has been linked to resistance to immunotherapy. However, recent studies have indicated possible heterogeneity in the immunovascular microenvironment in this subclass. We set out to test the hypothesis that specific immunovascular features might stratify W/B subclass HCCs into tumors having distinct aggressive natures., Methods: In this study, we analyzed 352 resected HCCs including 78 immunohistochemically defined W/B subclass HCCs. The density of tumor-infiltrating CD3
+ T cells and the area ratio of vessels encapsulating tumor clusters (VETC) were calculated on tissue specimens. The gene expressions of angiogenic factors were measured by quantitative reverse transcription-polymerase chain reaction. Disease-free survival (DFS) was assessed using multivariable Cox regression analyses., Results: The T-cell density of W/B subclass HCCs was regionally heterogenous within tumor tissues, and focally reduced T-cell density was observed in areas with VETC. VETC-positivity (defined as VETC area ratio greater than 1%) was inversely associated with T-cell infiltration in both W/B subclass and non-W/B subclass HCCs. Fibroblast growth factor 2 (FGF2) gene expression was higher in W/B subclass than in non-W/B subclass HCCs. The VETC-positivity and low T-cell density correlated with increased expression of FGF2 in W/B subclass HCCs. Additionally, VETC-positive HCCs showed significantly shorter DFS in W/B subclass HCCs., Conclusions: In conclusion, the immune and vascular microenvironments are interrelated and are also correlated with clinicopathological heterogeneity in W/B subclass HCC. These results could inform clinical practice and translational research on the development of therapeutic stratification of HCCs., (© 2022 Japan Society of Hepatology.)- Published
- 2023
- Full Text
- View/download PDF
41. Modulation of corticospinal excitability related to the forearm muscle during robot-assisted stepping in humans.
- Author
-
Kitamura T, Masugi Y, Yamamoto SI, Ogata T, Kawashima N, and Nakazawa K
- Subjects
- Humans, Electromyography, Muscle, Skeletal physiology, Leg physiology, Pyramidal Tracts physiology, H-Reflex physiology, Evoked Potentials, Motor physiology, Forearm physiology, Robotics
- Abstract
In recent years, the neural control mechanisms of the arms and legs during human bipedal walking have been clarified. Rhythmic leg stepping leads to suppression of monosynaptic reflex excitability in forearm muscles. However, it is unknown whether and how corticospinal excitability of the forearm muscle is modulated during leg stepping. The purpose of the present study was to investigate the excitability of the corticospinal tract in the forearm muscle during passive and voluntary stepping. To compare the neural effects on corticospinal excitability to those on monosynaptic reflex excitability, the present study also assessed the excitability of the H-reflex in the forearm muscle during both types of stepping. A robotic gait orthosis was used to produce leg stepping movements similar to those of normal walking. Motor evoked potentials (MEPs) and H-reflexes were evoked in the flexor carpi radialis (FCR) muscle during passive and voluntary stepping. The results showed that FCR MEP amplitudes were significantly enhanced during the mid-stance and terminal-swing phases of voluntary stepping, while there was no significant difference between the phases during passive stepping. Conversely, the FCR H-reflex was suppressed during both voluntary and passive stepping, compared to the standing condition. The present results demonstrated that voluntary commands to leg muscles, combined with somatosensory inputs, may facilitate corticospinal excitability in the forearm muscle, and that somatosensory inputs during walking play a major role in monosynaptic reflex suppression in forearm muscle., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
42. Movement-synchronized cerebellum rhythm coordinates multi-joint movements in young and elderly adults.
- Author
-
Hirata K, Hanawa H, Miyazawa T, and Masugi Y
- Subjects
- Humans, Adult, Aged, Walking, Locomotion, Joints
- Abstract
Rhythmic limb multi-joint movement like locomotion is controlled by intralimb coordination. Intralimb coordination changes entail immediate alterations in movement patterns and be related with cerebellum function. Synchronized cerebellum activity has known to modulate the frequency of walking, but not known the effect of only intralimb coordination. The purpose of this study was to reveal the effect of synchronized and unsynchronized cerebellum activity on the coordination of multi-joint movements of the unilateral leg in young and elderly people. To achieve our purpose, we applied synchronized and unsynchronized cerebellum transcranial alternating current stimulation during cyclic unilateral multi-joint movement by visual tracking task. The results showed that the reduction in comprehensive synchrony between targets and movements through trials had no significant differences under all stimulus conditions in young and elderly people. However, the reduction in variation of synchronization through trials was significantly smaller under the synchronized transcranial alternating current stimulation condition in both young and elderly groups. Variation of synchronization was remarkably reduced under the synchronized transcranial alternating current stimulation condition for the elderly group. This study showed that movement-synchronized cerebellum activity contributes to reducing fluctuations in movement synchrony by coordinating unilateral multi-joint movements. Moreover, this reduction was remarkable in the elderly group., Competing Interests: Competing interests The authors declare no competing or financial interests., (© 2023. Published by The Company of Biologists Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
43. Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS Imaging.
- Author
-
Kubo A, Masugi Y, Hase T, Nagashima K, Kawai Y, Takizawa M, Hishiki T, Shiota M, Wakui M, Kitagawa Y, Kabe Y, Sakamoto M, Yachie A, Hayashida T, and Suematsu M
- Abstract
Pathological examination of formalin-fixed paraffin-embedded (FFPE) needle-biopsied samples by certified pathologists represents the gold standard for differential diagnosis between ductal carcinoma in situ (DCIS) and invasive breast cancers (IBC), while information of marker metabolites in the samples is lost in the samples. Infrared laser-scanning large-area surface-enhanced Raman spectroscopy (SERS) equipped with gold-nanoparticle-based SERS substrate enables us to visualize metabolites in fresh-frozen needle-biopsied samples with spatial matching between SERS and HE staining images with pathological annotations. DCIS ( n = 14) and IBC ( n = 32) samples generated many different SERS peaks in finger-print regions of SERS spectra among pathologically annotated lesions including cancer cell nests and the surrounding stroma. The results showed that SERS peaks in IBC stroma exhibit significantly increased polysulfide that coincides with decreased hypotaurine as compared with DCIS, suggesting that alterations of these redox metabolites account for fingerprints of desmoplastic reactions to distinguish IBC from DCIS. Furthermore, the application of supervised machine learning to the stroma-specific multiple SERS signals enables us to support automated differential diagnosis with high accuracy. The results suggest that SERS-derived biochemical fingerprints derived from redox metabolites account for a hallmark of desmoplastic reaction of IBC that is absent in DCIS, and thus, they serve as a useful method for precision diagnosis in breast cancer., Competing Interests: The authors declare no conflict of interest. M.S. (Megumi Shiota) and FUJIFILM Corporation have no conflict of interest to be disclosed.
- Published
- 2023
- Full Text
- View/download PDF
44. Increased alpha cell to beta cell ratio in patients with pancreatic cancer.
- Author
-
Tsuchiya T, Saisho Y, Inaishi J, Sasaki H, Sato M, Nishikawa M, Masugi Y, Yamada T, and Itoh H
- Subjects
- Humans, Insulin, Pancreatic Neoplasms, Insulin-Secreting Cells, Pancreatic Neoplasms complications, Glucagon-Secreting Cells, Diabetes Mellitus
- Abstract
The development of pancreatic cancer (PC) is associated with worsening of glucose tolerance. However, there is limited information about the effects of PC on islet morphology. The aim of this study was to elucidate changes in alpha and beta cell mass in patients with PC. We enrolled 30 autopsy cases with death due to PC (9 with diabetes; DM) and 31 age- and BMI-matched autopsy cases without PC (controls, 12 with DM). Tumor-free pancreatic sections were stained for insulin and glucagon, and fractional beta cell (BCA) and alpha cell area (ACA) were quantified. In addition, expression of de-differentiation markers, i.e., ALDH1A3 and UCN3, was qualitatively evaluated. The pancreas of subjects with PC showed atrophic and fibrotic changes. There was no significant difference in BCA in subjects with PC compared to controls (1.53 ± 1.26% vs. 0.95 ± 0.42%, p = 0.07). However, ACA and ACA to BCA ratio were significantly higher in subjects with PC compared to controls (2.48 ± 2.39% vs. 0.53 ± 0.26% and 1.94 ± 1.93 vs. 0.59 ± 0.26, respectively, both p < 0.001). Increased ACA to BCA ratio was observed in subjects with PC irrespective of the presence of DM. Qualitative evaluation of ALDH1A3 and UCN3 expression showed no significant difference between the groups. In conclusion, in subjects with PC, alpha to beta cell mass ratio is increased, which may contribute to the increased risk of worsening glucose metabolism. Further studies are warranted to elucidate the mechanisms of increased alpha to beta cell mass in patients with PC.
- Published
- 2022
- Full Text
- View/download PDF
45. Changes in corticospinal and spinal reflex excitability through functional electrical stimulation with and without observation and imagination of walking.
- Author
-
Kaneko N, Sasaki A, Yokoyama H, Masugi Y, and Nakazawa K
- Abstract
Functional electrical stimulation (FES), a method for inducing muscle contraction, has been successfully used in gait rehabilitation for patients with deficits after neurological disorders and several clinical studies have found that it can improve gait function after stroke and spinal cord injury. However, FES gait training is not suitable for patients with walking difficulty, such as those with severe motor paralysis of the lower limbs. We have previously shown that action observation combined with motor imagery (AO + MI) of walking induces walking-related cortical activity. Therefore, we combined FES, which alternately generates dorsiflexion and plantar flexion, with AO + MI as an alternative to gait training. The present study investigates the transient effects of 20-min of FES simultaneously with and without AO + MI of walking on corticospinal and spinal reflex excitability in able-bodied participants. We measured motor evoked potentials and Hoffmann-reflexes to assess corticospinal and spinal reflex excitability at rest before and after the 20-min FES with and without the AO + MI. Our results show that FES without AO + MI did not change excitability ( p > 0.05), while FES with AO + MI facilitated corticospinal excitability ( p < 0.05). This facilitation likely occurred due to the synchronization of sensory inputs from FES and cortical activity during AO + MI. Facilitation was observed only in the dorsiflexor but not the plantar flexor muscle ( p < 0.05), suggesting muscle specificity of the facilitation. These results demonstrate the effectiveness of combining FES with AO + MI and pave the way for novel neurorehabilitation strategies for patients with neurological gait deficits., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Kaneko, Sasaki, Yokoyama, Masugi and Nakazawa.)
- Published
- 2022
- Full Text
- View/download PDF
46. KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.
- Author
-
Suzuki T, Masugi Y, Inoue Y, Hamada T, Tanaka M, Takamatsu M, Arita J, Kato T, Kawaguchi Y, Kunita A, Nakai Y, Nakano Y, Ono Y, Sasahira N, Takeda T, Tateishi K, Uemura S, Koike K, Ushiku T, Takeuchi K, Sakamoto M, Hasegawa K, Kitago M, Takahashi Y, and Fujishiro M
- Subjects
- Biomarkers, Tumor genetics, Gene Frequency, Humans, Mutation, Prognosis, Pancreatic Neoplasms, Pancreatic Neoplasms pathology, Proto-Oncogene Proteins p21(ras) genetics
- Abstract
KRAS mutation is a major driver of pancreatic carcinogenesis and will likely be a therapeutic target. Due to lack of sensitive assays for clinical samples of pancreatic cancer with low cellularity, KRAS mutations and their prognostic association have not been fully examined in large populations. In a multi-institutional cohort of 1162 pancreatic cancer patients with formalin-fixed paraffin-embedded tumor samples, we undertook droplet digital PCR (ddPCR) for KRAS codons 12/13/61. We examined detection rates of KRAS mutations by clinicopathological parameters and survival associations of KRAS mutation status. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) for disease-free survival (DFS) and overall survival (OS) were computed using the Cox regression model with adjustment for potential confounders. KRAS mutations were detected in 1139 (98%) patients. The detection rate did not differ by age of tissue blocks, tumor cellularity, or receipt of neoadjuvant chemotherapy. KRAS mutations were not associated with DFS or OS (multivariable HR comparing KRAS-mutant to KRAS-wild-type tumors, 1.04 [95% CI, 0.62-1.75] and 1.05 [95% CI, 0.60-1.84], respectively). Among KRAS-mutant tumors, KRAS variant allele frequency (VAF) was inversely associated with DFS and OS with HRs per 20% VAF increase of 1.27 (95% CI, 1.13-1.42; p
trend <0.001) and 1.31 (95% CI, 1.16-1.48; ptrend <0.001), respectively. In summary, ddPCR detected KRAS mutations in clinical specimens of pancreatic cancer with high sensitivity irrespective of parameters potentially affecting mutation detections. KRAS VAF, but not mutation positivity, was associated with survival of pancreatic cancer patients., (© 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)- Published
- 2022
- Full Text
- View/download PDF
47. The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities.
- Author
-
Masugi Y
- Abstract
Pancreatic cancer remains one of the most lethal malignancies and is becoming a dramatically increasing cause of cancer-related mortality worldwide. Abundant desmoplastic stroma is a histological hallmark of pancreatic ductal adenocarcinoma. Emerging evidence suggests a promising therapeutic effect of several stroma-modifying therapies that target desmoplastic stromal elements in the pancreatic cancer microenvironment. The evidence also unveils multifaceted roles of cancer-associated fibroblasts (CAFs) in manipulating pancreatic cancer progression, immunity, and chemotherapeutic response. Current state-of-the-art technologies, including single-cell transcriptomics and multiplexed tissue imaging techniques, have provided a more profound knowledge of CAF heterogeneity in real-world specimens from pancreatic cancer patients, as well as in genetically engineered mouse models. In this review, we describe recent advances in the understanding of the molecular pathology bases of pancreatic cancer desmoplastic stroma at multilayered levels of heterogeneity, namely, (1) variations in cellular and non-cellular members, including CAF subtypes and extracellular matrix (ECM) proteins; (2) geographical heterogeneity in relation to cell-cell interactions and signaling pathways at niche levels and spatial heterogeneity at locoregional levels or organ levels; and (3) intertumoral stromal heterogeneity at individual levels. This review further discusses the clinicopathological significance of desmoplastic stroma and the potential opportunities for stroma-targeted therapies against this lethal malignancy.
- Published
- 2022
- Full Text
- View/download PDF
48. Keio Uterus Transplantation Research: From Basic Research toward Future Clinical Application.
- Author
-
Kisu I, Banno K, Matoba Y, Yamada Y, Emoto K, Masugi Y, Matsubara K, Obara H, and Aoki D
- Subjects
- Animals, Female, Forecasting, Humans, Primates, Research, Uterus transplantation, Infertility, Female therapy
- Abstract
Uterus transplantation (UTx) is now a potential option to allow women with uterine factor infertility to give birth. However, UTx is still at an experimental stage, and basic animal studies, including in non-human primates, are needed for the accumulation of data prior to clinical application. Considering that UTx may provide new hope to Japanese women, we launched UTx research in 2009 and have since accumulated a large archive of results in the UTx research field. Furthermore, we have carried out various activities aimed at the implementation of clinical applications of UTx in Japan while clarifying the ethical and social issues involved. Currently, the clinical application of UTx in Japan is just around the corner, and it is expected that UTx research will develop further in the future. Herein, we summarize our basic experiences using non-human primates and our activities with the goal of future clinical applications.
- Published
- 2022
- Full Text
- View/download PDF
49. Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironments.
- Author
-
Kurebayashi Y, Matsuda K, Ueno A, Tsujikawa H, Yamazaki K, Masugi Y, Kwa WT, Effendi K, Hasegawa Y, Yagi H, Abe Y, Kitago M, Ojima H, and Sakamoto M
- Subjects
- Angiogenesis Inducing Agents, Humans, Prognosis, Tumor Microenvironment, Carcinoma, Hepatocellular pathology, Liver Neoplasms pathology
- Abstract
Background and Aims: Immune cells and tumor vessels constitute important elements in tumor tissue; however, their detailed relationship in human tumors, including HCC, is still largely unknown. Consequently, we expanded our previous study on the immune microenvironment of HCC and analyzed the relationship among the immune microenvironment, inflammatory/angiostatic factor expression, angiogenic factor expression, and tumor vessel findings, including vessels encapsulating tumor clusters (VETC) and macrotrabecular-massive (MTM) patterns., Approach and Results: We classified HCC into four distinct immunovascular subtypes (immune-high/angiostatic [IH/AS], immune-mid/angio-mid [IM/AM], immune-low/angiogenic [IL/AG], and immune-low/angio-low [IL/AL]). IH/AS, IM/AM, and IL/AG subtypes were associated with decreasing lymphocytic infiltration and increasing angiogenic factor expression and VETC/MTM positivity, reflecting their reciprocal interaction in the tumor microenvironment of HCC. IL/AG subtype was further characterized by CTNNB1 mutation and activation of Wnt/β-catenin pathway. IL/AL subtype was not associated with increased lymphocyte infiltration or angiogenic factor expression. Prognostically, IH/AS subtype and VETC/MTM positivity were independently significant in two independent cohorts. Increased angiogenic factor expression was not necessarily associated with VETC/MTM positivity and poor prognosis, especially when inflammatory/angiostatic milieu coexisted around tumor vessels. These results may provide insights on the therapeutic effects of immunotherapy, antiangiogenic therapies, and their combinations. The potential of evaluating the immunovascular microenvironment in predicting the clinical effect of these therapies in nonresectable HCC needs to be analyzed in the future study., Conclusions: HCC can be classified into four distinct immunovascular subtypes (IH/AS, IM/AM, IL/AG, and IL/AL) that reflect the reciprocal interaction between the antitumor immune microenvironment and tumor angiogenesis. In addition to its clinicopathological significance, immunovascular classification may also provide pathological insights on the therapeutic effect of immunotherapy, antiangiogenic therapy, and their combination., (© 2021 American Association for the Study of Liver Diseases.)
- Published
- 2022
- Full Text
- View/download PDF
50. Effects of action observation and motor imagery of walking on the corticospinal and spinal motoneuron excitability and motor imagery ability in healthy participants.
- Author
-
Kaneko N, Sasaki A, Yokoyama H, Masugi Y, and Nakazawa K
- Subjects
- Evoked Potentials, Motor physiology, Healthy Volunteers, Humans, Motor Neurons, Transcranial Magnetic Stimulation, Imagination physiology, Walking physiology
- Abstract
Action observation (AO) and motor imagery (MI) are used for the rehabilitation of patients who face difficulty walking. Rehabilitation involving AO, MI, and AO combined with MI (AO+MI) facilitates gait recovery after neurological disorders. However, the mechanism by which it positively affects gait function is unclear. We previously examined the neural mechanisms underlying AO and MI of walking, focusing on AO+MI and corticospinal and spinal motor neuron excitability, which play important roles in gait function. Herein, we investigated the effects of a short intervention using AO+MI of walking on the corticospinal and spinal motor neuron excitability and MI ability of participants. Twelve healthy individuals participated in this study, which consisted of a 20 min intervention. Before the experiment, we measured MI ability using the Vividness of Movement Imagery Questionnaire-2 (VMIQ-2). We used motor evoked potential and F-wave measurements to evaluate the corticospinal and spinal motor neuron excitability at rest, pre-intervention, 0 min, and 15 min post-intervention. We also measured corticospinal excitability during MI of walking and the participant's ability to perform MI using a visual analog scale (VAS). There were no significant changes in corticospinal and spinal motor neuron excitability during and after the intervention using AO+MI (p>0.05). The intervention temporarily increased VAS scores, thus indicating clearer MI (p<0.05); however, it did not influence corticospinal excitability during MI of walking (p>0.05). Furthermore, there was no significant correlation between the VMIQ-2 and VAS scores and changes in corticospinal and spinal motor neuron excitability. Therefore, one short intervention using AO+MI increased MI ability in healthy individuals; however, it was insufficient to induce plastic changes at the cortical and spinal levels. Moreover, the effects of intervention using AO+MI were not associated with MI ability. Our findings provide information about intervention using AO+MI in healthy individuals and might be helpful in planning neurorehabilitation strategies., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.